241 related articles for article (PubMed ID: 20889205)
21. Vascular-targeted nanotherapy for obesity: unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery.
Hossen MN; Kajimoto K; Akita H; Hyodo M; Harashima H
J Control Release; 2012 Oct; 163(2):101-10. PubMed ID: 22982237
[TBL] [Abstract][Full Text] [Related]
22. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
23. Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.
Lim SM; Kim TH; Jiang HH; Park CW; Lee S; Chen X; Lee KC
Biomaterials; 2011 May; 32(13):3538-46. PubMed ID: 21306770
[TBL] [Abstract][Full Text] [Related]
24. Amino acids and peptides. XXXIII. A bifunctional poly(ethylene glycol) hybrid of laminin-related peptides.
Maeda M; Kawasaki K; Mu Y; Kamada H; Tsutsumi Y; Smith TJ; Mayumi T
Biochem Biophys Res Commun; 1998 Jul; 248(3):485-9. PubMed ID: 9703952
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice.
Bibby DC; Talmadge JE; Dalal MK; Kurz SG; Chytil KM; Barry SE; Shand DG; Steiert M
Int J Pharm; 2005 Apr; 293(1-2):281-90. PubMed ID: 15778066
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
[TBL] [Abstract][Full Text] [Related]
27. Identification of metastasis-promoting sequences in the mouse laminin alpha 1 chain.
Kuratomi Y; Nomizu M; Nielsen PK; Tanaka K; Song SY; Kleinman HK; Yamada Y
Exp Cell Res; 1999 Jun; 249(2):386-95. PubMed ID: 10366438
[TBL] [Abstract][Full Text] [Related]
28. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
29. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
30. New analogues of laminin active fragment YIGSR: synthesis and biological activity in vitro and in vivo.
Witkowska E; Oriowska A; Izdebski J; Salwa J; Wietrzyk J; Opolski A
J Pept Sci; 2004 May; 10(5):285-90. PubMed ID: 15160840
[TBL] [Abstract][Full Text] [Related]
31. Lung carcinoma imaging using a synthetic laminin derivative radioiodinated peptide YIGSR.
Koliakos G; Trontzos C; Kouzi-Koliakos K; Kanellaki M; Grammaticos P
J Nucl Med; 1997 Dec; 38(12):1940-4. PubMed ID: 9430474
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration.
Huang R; Ke W; Han L; Li J; Liu S; Jiang C
Biomaterials; 2011 Mar; 32(9):2399-406. PubMed ID: 21185076
[TBL] [Abstract][Full Text] [Related]
33. Liver targeting and the delayed drug release of the nanoparticles of adriamycin polybutylcyanoacrylate in mice.
Shen LF; Zhang YD; Shen HJ; Zeng S; Wang X; Wang C; Le Y; Shen H
Chin Med J (Engl); 2006 Aug; 119(15):1287-93. PubMed ID: 16919188
[TBL] [Abstract][Full Text] [Related]
34. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
35. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan.
Engbring JA; Hoffman MP; Karmand AJ; Kleinman HK
Cancer Res; 2002 Jun; 62(12):3549-54. PubMed ID: 12068003
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW
Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794
[TBL] [Abstract][Full Text] [Related]
37. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
38. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
39. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.
Yoshida N; Ishii E; Nomizu M; Yamada Y; Mohri S; Kinukawa N; Matsuzaki A; Oshima K; Hara T; Miyazaki S
Br J Cancer; 1999 Aug; 80(12):1898-904. PubMed ID: 10471037
[TBL] [Abstract][Full Text] [Related]
40. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.
Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ
Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]